BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18829503)

  • 1. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
    Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
    Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of nuclear extract proteins from human neuroblastoma cell lines: the search for fingerprints.
    Escobar MA; Hoelz DJ; Sandoval JA; Hickey RJ; Grosfeld JL; Malkas LH
    J Pediatr Surg; 2005 Feb; 40(2):349-58. PubMed ID: 15750928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
    Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
    Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
    Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
    Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics.
    Suehara Y; Kondo T; Seki K; Shibata T; Fujii K; Gotoh M; Hasegawa T; Shimada Y; Sasako M; Shimoda T; Kurosawa H; Beppu Y; Kawai A; Hirohashi S
    Clin Cancer Res; 2008 Mar; 14(6):1707-17. PubMed ID: 18347171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
    Krajewski S; Chatten J; Hanada M; Reed JC
    Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis.
    Cheng AL; Huang WG; Chen ZC; Peng F; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Yi B; Xiao ZQ
    Clin Cancer Res; 2008 Jan; 14(2):435-45. PubMed ID: 18223218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage.
    Hoehner JC; Gestblom C; Hedborg F; Sandstedt B; Olsen L; PĂ„hlman S
    Lab Invest; 1996 Nov; 75(5):659-75. PubMed ID: 8941212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive profiling of the cell surface proteome of Sy5Y neuroblastoma cells yields a subset of proteins associated with tumor differentiation.
    Garcia J; Faca V; Jarzembowski J; Zhang Q; Park J; Hanash S
    J Proteome Res; 2009 Aug; 8(8):3791-6. PubMed ID: 19505085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of neuroblastoma subtypes in response to mitogen-activated protein kinase inhibition: profiling multiple targets of cancer kinase signaling.
    Sandoval JA; Eppstein AC; Hoelz DJ; Klein PJ; Linebarger JH; Turner KE; Rescorla FJ; Hickey RJ; Malkas LH; Schmidt CM
    J Surg Res; 2006 Jul; 134(1):61-7. PubMed ID: 16650873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in neuroblastoma: correlation with clinical features, cellular localization, and cerulenin-mediated apoptosis regulation.
    Geerts D; Wallick CJ; Koomoa DL; Koster J; Versteeg R; Go RC; Bachmann AS
    Clin Cancer Res; 2007 Nov; 13(21):6312-9. PubMed ID: 17975142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis.
    Cheng AL; Huang WG; Chen ZC; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Peng F; Duan CJ; Xiao ZQ
    J Proteome Res; 2008 Jun; 7(6):2415-26. PubMed ID: 18433155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features.
    Ball NS; King PH
    Clin Cancer Res; 1997 Oct; 3(10):1859-65. PubMed ID: 9815574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traditional and emerging molecular markers in neuroblastoma prognosis: the good, the bad and the ugly.
    Poremba C; Hero B; Goertz HG; Scheel C; Wai D; Schaefer KL; Christiansen H; Berthold F; Juergens H; Boecker W; Dockhorn-Dworniczak B
    Klin Padiatr; 2001; 213(4):186-90. PubMed ID: 11528552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
    Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
    Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel peptides secreted from human neuroblastoma: useful clinical tools?
    Sandoval JA; Hoelz DJ; Woodruff HA; Powell RL; Jay CL; Grosfeld JL; Hickeyd RJ; Malkas LH
    J Pediatr Surg; 2006 Jan; 41(1):245-51. PubMed ID: 16410142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of DDX39A as a Potential Biomarker for Unfavorable Neuroblastoma Using a Proteomic Approach.
    Otake K; Uchida K; Ide S; Kobayashi Y; Kobayashi I; Kusunoki M
    Pediatr Blood Cancer; 2016 Feb; 63(2):221-7. PubMed ID: 26469522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroblastoma detection using serum proteomic profiling: a novel mining technique for cancer?
    Sandoval JA; Dobrolecki LE; Huang J; Grosfeld JL; Hickey RJ; Malkas LH
    J Pediatr Surg; 2006 Apr; 41(4):639-46; discussion 639-46. PubMed ID: 16567169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.
    Kramer K; Gerald W; LeSauteur L; Uri Saragovi H; Cheung NK
    Clin Cancer Res; 1996 Aug; 2(8):1361-7. PubMed ID: 9816308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 signaling in human neuroblastoma progression.
    Ngan ES; Sit FY; Lee K; Miao X; Yuan Z; Wang W; Nicholls JM; Wong KK; Garcia-Barcelo M; Lui VC; Tam PK
    Clin Cancer Res; 2007 Feb; 13(3):868-75. PubMed ID: 17289879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.